FDA称，如果欣百达获得批准，它将是第一个非传统慢性疼痛止痛药。
If approved, the FDA said Cymbalta would be the first nontraditional analgesic approved for chronic pain.
这项研究针对于用于治疗抑郁症和综合焦虑失调症的度洛西汀或欣百达。
The study looked at the drug duloxetine, or Cymbalta, which is used to treat depression and generalized anxiety disorder.
礼来公司正在向FDA申请将欣百达适应症扩展到慢性疼痛，例如因关节炎导致的膝盖疼痛和腰疼。
Lilly is seeking FDA approval for Cymbalta as a treatment for chronic pain conditions such as knee pain caused by osteoarthritis and lower back pain.
应用推荐